Ten big drug companies that have spent billions racing one another to find breakthroughs on diseases like Alzheimer's have formed an unusual pact to cooperate on a government-backed effort to accelerate the discovery of new medicines.. Under a five-year collaboration to be announced on Tuesday, the companies and the National Institutes of Health have agreed to share scientists, tissue and blood samples, and data. They aim to decipher the biology behind Alzheimer's, Type 2 diabetes, rheumatoid arthritis and lupus, and to thereby...
  